The Prostate

Cover image for The Prostate

1 March 2006

Volume 66, Issue 4

Pages 335–445

  1. Research Articles

    1. Top of page
    2. Research Articles
    3. Errata
    1. A preliminary analysis and model of prostate injection distributions (pages 344–357)

      Scott L. Chowning, Robert C. Susil, Axel Krieger, Gabor Fichtinger, Louis L. Whitcomb and Ergin Atalar

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20298

    2. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug (pages 358–368)

      Samuel Janssen, D. Marc Rosen, Rebecca M. Ricklis, Craig A. Dionne, Hans Lilja, Soeren B. Christensen, John T. Isaacs and Samuel R. Denmeade

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20348

    3. Prostate cell lines secrete IL-8 in response to mycoplasma hominis through Toll-like receptor 2-mediated mechanism (pages 386–391)

      Koh Takeyama, Hiroaki Mitsuzawa, Takeyuki Shimizu, Masanori Konishi, Chiaki Nishitani, Hitomi Sano, Yasuharu Kunishima, Masanori Matsukawa, Satoshi Takahashi, Ken-ichiro Shibata, Taiji Tsukamoto and Yoshio Kuroki

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20358

    4. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia (pages 392–404)

      Rosebud O. Roberts, Erik J. Bergstralh, Sara A. Farmer, Debra J. Jacobson, Scott J. Hebbring, Julie M. Cunningham, Stephen N. Thibodeau, Michael M. Lieber and Steven J. Jacobsen

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20362

    5. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers (pages 405–412)

      Wei Lu, Hiroyuki Takahashi, Masakuni Furusato, Suguru Maekawa, Masataka Nakano, Chenxi Meng, Yasushi Kikuchi, Akemi Sudo and Hiroshi Hano

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20363

    6. The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide (pages 413–420)

      Alfred Hobisch, Andreas Fritzer, Barbara Comuzzi, Matthias Fiechtl, Kamilla Malinowska, Hannes Steiner, Georg Bartsch and Zoran Culig

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20365

    7. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas (pages 421–429)

      Ajay P. Singh, Subhash C. Chauhan, Sangeeta Bafna, Sonny L. Johansson, Lynette M. Smith, Nicolas Moniaux, Ming-Fong Lin and Surinder K. Batra

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20372

    8. Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound (pages 430–438)

      Fuminori Teraishi, Shuhong Wu, Satoshi Inoue, Lidong Zhang, John J. Davis, Wei Guo, Fengqin Dong and Bingliang Fang

      Version of Record online: 21 NOV 2005 | DOI: 10.1002/pros.20373

    9. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer (pages 439–444)

      Haruki Kaku, Takashi Saika, Tomoyasu Tsushima, Shin Ebara, Takashi Senoh, Toyoko Yamato, Yasutomo Nasu and Hiromi Kumon

      Version of Record online: 2 DEC 2005 | DOI: 10.1002/pros.20341

  2. Errata

    1. Top of page
    2. Research Articles
    3. Errata
    1. You have free access to this content

SEARCH

SEARCH BY CITATION